{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:10:42Z","timestamp":1788930642766,"version":"build-2803163510"},"reference-count":67,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Center of Excellence in Informatics and ICT","award":["BG16RFPR002-1.014-0018-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0018-C01"]}]},{"award":["BG16RFPR002-1.014-0018-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0018-C01"]}],"id":[{"id":"https:\/\/ror.org\/02y9qjz38","id-type":"ROR","asserted-by":"publisher"}]},{"name":"the Science and Education for Smart Growth Operational Program","award":["BG16RFPR002-1.014-0018-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0018-C01"]}]},{"name":"the European Union through the European Structural and Investment funds","award":["BG16RFPR002-1.014-0018-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0018-C01"]}]},{"award":["BG16RFPR002-1.014-0018-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0018-C01"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Building on earlier work with methoxy-, dimethoxy-, bromo-, and nitro-substituted salicylaldehyde benzoylhydrazones, we synthesized and evaluated new 4-chloro- and 5-chloro derivatives bearing an additional chlorine substituent on the hydrazide-derived phenyl ring to further explore the impact of halogenation on cytotoxic activity. Methods: Chloro-hydrazones were obtained through a one-step condensation of 4- or 5-chlorosalicylaldehyde with benzhydrazide or 2-, 3-, and 4-chlorobenzhydrazides. Their physicochemical, pharmacokinetic, ADME, lead-likeness, and drug-likeness profiles were evaluated in silico using SwissADME, ACD\/Labs v9.10, and MDL QSAR v2.2.0.0.446. The synthesized compounds were structurally characterized by IR, 1H NMR, 13C NMR, and HR ESI\u2013MS, and their cytotoxic activity was subsequently assessed by the MTT assay in selected cancer cell lines. Molecular docking was performed against ABL1 tyrosine kinase (ABL1 TK), a potential molecular target relevant to two of the investigated leukemia cell lines, using GOLD v.5.2.2 (CCDC Ltd., Cambridge, UK). Results: The chloro-substituted salicylaldehyde benzoylhydrazones exhibited pronounced, cell-type-dependent cytotoxicity, with leukemia cells being substantially more sensitive than breast carcinoma cells. Most derivatives showed low- to sub-micromolar IC50 values against SKW-3 human T-cell prolymphocytic leukemia, K-562 human chronic myeloid (myelogenous) leukemia, and BV-173 human BCR::ABL1-positive leukemia cells, with K3 and K4 exhibiting the highest activity in SKW-3 cells (IC50 = 0.5 \u00b1 0.1 \u00b5M). K5 showed particularly strong activity against K-562 and BV-173 cells (IC50 = 0.7 \u00b1 0.1 and 0.9 \u00b1 0.1 \u00b5M, respectively), compared with 26.9 \u00b1 2.4 and 21.5 \u00b1 3.3 \u00b5M for imatinib. HL-60 human acute promyelocytic leukemia cells showed intermediate sensitivity (IC50 = 1.3\u201313.9 \u00b5M), whereas the activity against MCF-7 estrogen receptor-positive and MDA-MB-231 triple-negative breast carcinoma cells was more variable (1.5\u201332.1 and 4.1\u201362.5 \u00b5M, respectively). The derivatives showed high selectivity toward malignant cells relative to non-malignant CCL-1 non-malignant mouse fibroblasts, with lower-bound SI values frequently exceeding 50 and reaching &gt;200 in SKW-3 cells. Conclusions: The chloro-substituted salicylaldehyde benzoylhydrazones exhibited pronounced and selective cytotoxicity, particularly toward leukemia cell lines, identifying this scaffold as a promising starting point for further anticancer drug-discovery studies.<\/jats:p>","DOI":"10.3390\/ph19091387","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:28:22Z","timestamp":1788280102000},"page":"1387","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, Synthesis, and Integrated In Silico and In Vitro Evaluation of Chloro-Substituted Salicylaldehyde Benzoylhydrazones as Anticancer Agents"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-9247","authenticated-orcid":false,"given":"Boryana","family":"Nikolova-Mladenova","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"},{"name":"Centre of Excellence in Informatics and Information and Communication Technologies, 1113 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0730","authenticated-orcid":false,"given":"Rositsa","family":"Mihaylova","sequence":"additional","affiliation":[{"name":"Centre of Excellence in Informatics and Information and Communication Technologies, 1113 Sofia, Bulgaria"},{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stilyana","family":"Kostova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Vasilev","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-1768","authenticated-orcid":false,"given":"Irini","family":"Doytchinova","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"},{"name":"Centre of Excellence in Informatics and Information and Communication Technologies, 1113 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-0355","authenticated-orcid":false,"given":"Mariyana","family":"Atanasova","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"},{"name":"Centre of Excellence in Informatics and Information and Communication Technologies, 1113 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological Activities of Hydrazone Derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0975-7406.129170","article-title":"A Review Exploring Biological Activities of Hydrazones","volume":"6","author":"Verma","year":"2014","journal-title":"J. Pharm. Bioall Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1389557519666191014142448","article-title":"Synthesis and Biological Activity of Hydrazones and Derivatives: A Review","volume":"20","author":"LaPlante","year":"2020","journal-title":"MRMC"},{"key":"ref_4","unstructured":"Dhiman, T., Sharma, S., and Duggal, S. (2025). Biological Activities of Hydrazones: A Comprehensive Review. WJPPS, 14."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Socea, L.-I., Barbuceanu, S.-F., Pahontu, E.M., Dumitru, A.-C., Nitulescu, G.M., Sfetea, R.C., and Apostol, T.-V. (2022). Acylhydrazones and Their Biological Activity: A Review. Molecules, 27.","DOI":"10.3390\/molecules27248719"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"29912","DOI":"10.1038\/s41598-024-81555-z","article-title":"Insights into the Pharmaceutical Properties and in Silico Study of Novel Hydrazone Derivatives","volume":"14","author":"Ibraheem","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00044-016-1756-y","article-title":"Hydrazide\u2013Hydrazones as Potential Antimicrobial Agents: Overview of the Literature since 2010","volume":"26","year":"2017","journal-title":"Med. Chem. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Popio\u0142ek, \u0141. (2021). Updated Information on Antimicrobial Activity of Hydrazide\u2013Hydrazones. IJMS, 22.","DOI":"10.3390\/ijms22179389"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.2147\/DDDT.S521541","article-title":"Synthesis, Molecular Characterization, and Antimicrobial Evaluation of Hydrazones Derived from 2-Hydrazinobenzimidazole","volume":"19","author":"Riyadh","year":"2025","journal-title":"DDDT"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1016\/j.bmc.2014.07.022","article-title":"Synthesis and Antifungal Activity of Substituted Salicylaldehyde Hydrazones, Hydrazides and Sulfohydrazides","volume":"22","author":"Backes","year":"2014","journal-title":"Bioorganic Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.3390\/molecules20059229","article-title":"Synthesis and Biological Evaluation of Hydrazone Derivatives as Antifungal Agents","volume":"20","author":"Casanova","year":"2015","journal-title":"Molecules"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.ejmech.2009.04.001","article-title":"Synthesis of New Acridines and Hydrazones Derived from Cyclic \u03b2-Diketone for Cytotoxic and Antiviral Evaluation","volume":"44","author":"Rady","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijtb.2025.03.003","article-title":"Synthesis, Characterization, and in Silico Studies on New Series of Hydrazide-Hydrazones for Potential Anti-Tubercular Agents","volume":"73","author":"Bollikolla","year":"2026","journal-title":"Indian. J. Tuberc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.33545\/26646781.2025.v7.i7b.511","article-title":"Synthesis and Anti-Tubercular Activity Evaluation of Hydrazide-Hydrazone Derivatives","volume":"7","author":"Connelly","year":"2025","journal-title":"Int. J. Adv. Chem. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zlatanova-Tenisheva, H., and Vladimirova, S. (2025). Pharmacological Evaluation of Novel Hydrazide and Hydrazone Derivatives: Anti-Inflammatory and Analgesic Potential in Preclinical Models. Molecules, 30.","DOI":"10.3390\/molecules30071472"},{"key":"ref_16","first-page":"1","article-title":"Therapeutic Potential of Hydrazones as Anti-Inflammatory Agents","volume":"2014","author":"Kajal","year":"2014","journal-title":"Int. J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"138634","DOI":"10.1016\/j.molstruc.2024.138634","article-title":"Synthesis, Anti-Inflammatory, Antibacterial, and Antioxidant Evaluation of Novel Pyrazole-Linked Hydrazone Derivatives","volume":"1312","author":"Kamat","year":"2024","journal-title":"J. Mol. Struct."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41456","DOI":"10.1038\/s41598-025-26016-x","article-title":"Novel Triazole-Carbohydrazide Hydrazones with Dual Antioxidant and Antibacterial Potential","volume":"15","author":"Badawy","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0928-0987(02)00077-5","article-title":"Anticonvulsant Activity of Hydrazones, Schiff and Mannich Bases of Isatin Derivatives","volume":"16","author":"Sridhar","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Al Nasr, I.S., Koko, W.S., Khan, T.A., Schobert, R., and Biersack, B. (2024). Antiparasitic Activities of Acyl Hydrazones from Cinnamaldehydes and Structurally Related Fragrances. Antibiotics, 13.","DOI":"10.3390\/antibiotics13121114"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118305","DOI":"10.1016\/j.ejmech.2025.118305","article-title":"Anticancer Activity of Hydrazones in the Last Quinquennial Period: A Special Emphasis on Various Enzyme Targets and SAR","volume":"302","author":"Charan","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1080\/10406638.2025.2573682","article-title":"Unraveling the Anticancer Activity of Newly Synthesized Acylhydrazones and Hydrazones: In Vitro and Computational Insights","volume":"45","author":"Hussein","year":"2025","journal-title":"Polycycl. Aromat. Compd."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"138012","DOI":"10.1016\/j.molstruc.2024.138012","article-title":"Hydrazide-Hydrazone\/Hydrazone as Enabling Linkers in Anti-Cancer Drug Discovery: A Comprehensive Review","volume":"1307","author":"Murugappan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"20073","DOI":"10.1021\/acsomega.3c02361","article-title":"Novel N -Acyl Hydrazone Compounds as Promising Anticancer Agents: Synthesis and Molecular Docking Studies","volume":"8","author":"Biliz","year":"2023","journal-title":"ACS Omega"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44371-025-00463-x","article-title":"An Overview on Synthetic Aspects and Biological Activity Profiles of Hydrazone Derivatives","volume":"3","author":"Pai","year":"2026","journal-title":"Discov. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1107\/S0108270195003076","article-title":"Salicylaldehyde Benzoyl Hydrazone","volume":"51","author":"Lyubchova","year":"1995","journal-title":"Acta Crystallogr. C Cryst. Struct. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:STUC.0000026744.76622.2c","article-title":"Salicylaldehyde Benzoyl Hydrazone: Isomerization Due to Water. A Structural Analysis Using a Combination of NMR, IR, and Theoretical Investigations","volume":"15","author":"Cordier","year":"2004","journal-title":"Struct. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pot\u016f\u010dkov\u00e1, E., Hru\u0161kov\u00e1, K., Bure\u0161, J., Kova\u0159\u00edkov\u00e1, P., \u0160pirkov\u00e1, I.A., Pravd\u00edkov\u00e1, K., Kolbabov\u00e1, L., Hergeselov\u00e1, T., Ha\u0161kov\u00e1, P., and Jansov\u00e1, H. (2014). Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112059"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"151872","DOI":"10.1016\/j.bbrc.2025.151872","article-title":"Salicylaldehyde-Derived Hydrazones: Synthesis, Characterization, Antibacterial Activity, Antioxidant and Anti-Inflammatory Effects on LPS-Induced RAW264.7 Macrophage Cells, Drug-Likeness Properties, and Molecular Docking Analysis","volume":"766","author":"Necip","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/00958972.2024.2371430","article-title":"Salicylaldehyde Salicyloyl Hydrazone and Its Copper(II) Complex: Synthesis, Characterization, DFT, Optical Band Gap, Antibacterial Activity, and Molecular Docking Analysis","volume":"77","author":"Sharma","year":"2024","journal-title":"J. Coord. Chem."},{"key":"ref_31","first-page":"714","article-title":"Synthesis, Characterization and Cytotoxic Activity of New Salicylaldehyde Benzoylhydrazone Derivatives as Potential Anti-Proliferative Agents","volume":"61","author":"Halachev","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"ref_32","first-page":"41","article-title":"Synthesis and Physicochemical Characterization of New Salicylaldehyde Benzoyl Hydrazone Derivative with High Cytotoxic Activity","volume":"58","author":"Momekov","year":"2011","journal-title":"Pharmacia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jab.2017.04.004","article-title":"Design and Drug-like Properties of New 5-Methoxysalicylaldehyde Based Hydrazones with Anti-Breast Cancer Activity","volume":"15","author":"Momekov","year":"2017","journal-title":"J. Appl. Biomed."},{"key":"ref_34","first-page":"44","article-title":"Comparative Evaluation of in Silico and In Vitro Pharmacological Activity of Some 5-Nitrosalicylaldehyde-Derived Hydrazones","volume":"1","author":"Gerasimova","year":"2014","journal-title":"J. Med. Biolog. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nikolova-Mladenova, B., Angelova, S., and Momekov, G. (2022). Gallium (III) Complexes with 5-Bromosalicylaldehyde Benzoylhydrazones: In Silico Studies and In Vitro Cytotoxic Activity. Molecules, 27.","DOI":"10.3390\/molecules27175493"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Nikolova-Mladenova, B., Momekov, G., Zhivkova, Z., and Doytchinova, I. (2023). Design, Synthesis and Cytotoxic Activity of Novel Salicylaldehyde Hydrazones against Leukemia and Breast Cancer. IJMS, 24.","DOI":"10.3390\/ijms24087352"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Nikolova-Mladenova, B., Mihaylova, R., Atanasova, M., Zhivkova, Z., and Doytchinova, I. (2025). Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation. Molecules, 30.","DOI":"10.3390\/molecules30051015"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/17568919.2026.2629538","article-title":"Key Contemporary Considerations for Halogens in Drug Discovery","volume":"18","author":"Ali","year":"2026","journal-title":"Future Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138945010790711996","article-title":"Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design","volume":"11","author":"Hernandes","year":"2010","journal-title":"CDT"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1021\/acs.jmedchem.8b01453","article-title":"Halogens in Protein\u2013Ligand Binding Mechanism: A Structural Perspective","volume":"62","author":"Shinada","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1021\/acs.jmedchem.2c02015","article-title":"\u201cMagic Chloro\u201d: Profound Effects of the Chlorine Atom in Drug Discovery","volume":"66","author":"Chiodi","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117380","DOI":"10.1016\/j.ejmech.2025.117380","article-title":"Highlights on U.S. FDA-Approved Halogen-Containing Drugs in 2024","volume":"287","author":"Ali","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jps.22819","article-title":"Prediction of Steady-State Volume of Distribution of Acidic Drugs by Quantitative Structure\u2013Pharmacokinetics Relationships","volume":"101","author":"Zhivkova","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1002\/jps.23303","article-title":"Quantitative Structure\u2014Plasma Protein Binding Relationships of Acidic Drugs","volume":"101","author":"Zhivkova","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1021\/mp400251k","article-title":"Quantitative Structure\u2013Clearance Relationships of Acidic Drugs","volume":"10","author":"Zhivkova","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and Drug-like Compounds: The Rule-of-Five Revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","article-title":"Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs","volume":"16","author":"Kelder","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2174\/15680266113139990035","article-title":"Permeability Diagnosis Model in Drug Discovery: A Diagnostic Tool to Identify the Most Influencing Properties for Gastrointestinal Permeability","volume":"13","author":"Wang","year":"2013","journal-title":"CTMC"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","article-title":"How Big Is Too Big for Cell Permeability?","volume":"60","author":"Matsson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal Chemical Properties of Successful Central Nervous System Drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"Neurotherapeutics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure\u2212Brain Exposure Relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U","article-title":"The Design of Leadlike Combinatorial Libraries","volume":"38","author":"Teague","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural Basis of the Drug-Binding Specificity of Human Serum Albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/ci300155y","article-title":"In Silico Prediction of Total Human Plasma Clearance","volume":"52","author":"Berellini","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102247","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural Features of the Protein Kinase Domain and Targeted Binding by Small-Molecule Inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/jm400072p","article-title":"Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors","volume":"56","author":"Peng","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1107\/S0907444906047287","article-title":"Structural Biology Contributions to the Discovery of Drugs to Treat Chronic Myelogenous Leukaemia","volume":"63","author":"Fendrich","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_59","unstructured":"(2021). BIOVIA Discovery Studio Visualizer, Dassault Syst\u00e8mes. version 21.1.0.20298."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0162-0134(99)00131-2","article-title":"Cytotoxicity of Salicylaldehyde Benzoylhydrazone Analogs and Their Transition Metal Complexes: Quantitative Structure\u2013Activity Relationships","volume":"77","author":"Ainscough","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.bmcl.2012.03.060","article-title":"Synthesis, Characterization, Molecular Docking and Cytotoxic Activity of Novel Plumbagin Hydrazones against Breast Cancer Cells","volume":"22","author":"Dandawate","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.bmc.2013.08.026","article-title":"Synthesis and Biological Evaluation of Novel Acylhydrazone Derivatives as Potential Antitumor Agents","volume":"21","author":"Congiu","year":"2013","journal-title":"Bioorganic Med. Chem."},{"key":"ref_63","first-page":"4236","article-title":"Crystal Structures of the Kinase Domain of C-Abl in Complex with the Small Molecule Inhibitors PD173955 and Imatinib (STI-571)","volume":"62","author":"Nagar","year":"2002","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/cb500129t","article-title":"Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?","volume":"9","author":"Zhao","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_66","unstructured":"(2004). MDL QSAR, MDL Information Systems, Inc.. version 2.2.0.0.446."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and Validation of a Genetic Algorithm for Flexible Docking 1 1Edited by F. E. Cohen","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1387\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:42:42Z","timestamp":1788928962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091387"],"URL":"https:\/\/doi.org\/10.3390\/ph19091387","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}